HireQuest, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HireQuest, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	98.1	97.4	12.3	15.9	13.8	22.5	31	37.9	34.6	30.6
Cost of revenue	72.6	72.5			0	0.17
Gross profit	25.4	24.9			13.8	22.6
Selling, general and administrative	21.3	23.4	5.33	12.7	8.7	13.3	12.9	24.4	21.4	20.7
Selling and marketing			0.01	0.45	0.03	0.09	0.27	1.2	1.4	1.7
Operating income	3.7	1.18	6.91	2.78	4.98	7.65	16	10.6	4.37	6.28
Interest expense	0.01	0	0.02	0.56	0.05	0.16	0.37	1.39	0.92	0.31
Interest income					0.71	0.41	0.25	0.26	0.56	0.51
Other non-operating income			0.19	0.75	0.46	4.57	-2.05	-1.74	0.15	0.22
Pre-tax income	3.68	1.18	7.08	2.98	6.1	12.5	13.9	7.78	4.15	6.71
Income tax	2.01	0.21	0.02	3.48	0.74	0.64	1.9	1.35	0.22	0.1
Income from continuing operations			7.06	-0.51	5.36			6.44	3.93	6.61
Net income	1.68	0.97	7.12	-0.29	5.36	11.9	12.5	6.14	3.67	6.33
EBITDA	3.86	1.35	7	3.18	5.11	9.2	18.1	13.4	7.16	9.29
EPS, basic	0.33	0.20	0.72	-0.03	0.40	0.88	0.91	0.45	0.27	0.45
EPS, diluted	0.33	0.20	0.72	-0.03	0.39	0.87	0.91	0.45	0.26	0.45
Shares, basic (weighted)	5.04	4.85	9.94	11.6	13.5	13.5	13.7	13.7	13.8	14
Shares, diluted (weighted)	5.11	4.86	9.94	11.6	13.7	13.6	13.7	13.8	13.9	14
Dividend per share							0.06	0.24	0.24	0.24

Balance sheet

	FY2017	FY2018	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	7.78	8	1.29	4.19	13.7	1.26	3.05	1.34	2.22	3.9
Receivables	9.39	20.7	20.7	28.2	21.3	38.2	45.7	44.4	42.3	39.3
Other current assets		0	0	0.2	0	0.66	1.83	3.28	2.41	3.25
Total current assets	18.2	22.2	22.2	37	39	42	51.9	51.5	49.2	48.3
Property, plant and equipment	0.37	2.05	2.05	1.9	3.19	4.45	4.35	4.28	4.15	4.05
Lease right-of-use assets		0
Goodwill	3.78					0	5.87	5.87	1.63	1.63
Intangible assets	4.09	3.93		0	0.34	22.9	25.8	25.8	28.2	24.2
Other non-current assets		0.01	0.01	0	0	0.33	0.33	0.1	0.06	0.28
Total assets	25.4	24.4	24.4	46.9	49.1	77.4	103	104	94	88.2
Accounts payable	0.56	0.05	0.05	0.25	0.46	1.13	0.45	0.14	0.17	0.19
Total current liabilities	4.85	10.9	12.7	11	9.46	21.5	36.8	35.7	24.1	15.3
Long-term debt						2.86
Lease liabilities		0
Total liabilities	5.77	11.6	13.4	15.6	12.7	30.6	45	41.1	29.2	19.9
Total debt						2.86
Paid-in capital	56.2	6.94	6.94	27.6	28.8	30.5	32.8	34.5	36.3	37.2
Retained earnings	-36.6	5.78	3.97	3.68	7.69	16.4	25.5	28.3	28.7	31.2
Treasury stock				0	-0.15	-0.15	-0.15	-0.15	-0.15	-0.15
Shareholders' equity	12.6	10.9	10.9	31.3	36.4	46.7	58.3	62.7	64.8	68.3
Total equity	12.6	10.9	10.9	31.3	36.4	46.7	58.3	62.7	64.8	68.3
Total liabilities and equity	25.4	24.4	24.4	46.9	49.1	77.4	103	104	94	88.2
Shares outstanding	4.99	9.94	9.94	13.5	13.6

Cash flow statement

	FY2017	FY2018	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1.68	0.97	7.12	-0.29	5.36	11.9	12.5	6.14	3.67	6.33
Depreciation and amortization	0.17	0.17	0.09	0.4	0.13	1.55	2.04	2.79	2.79	3.01
Stock-based compensation	0.16	0.33	0	0.76	1.23	1.63	2.37	1.68	1.76	0.94
Deferred income tax					-1.77	-2.37	-0.41	-0.35	-1.75	0.17
Change in receivables	0.68	0.28	-0.73	-7.48	6.86	-3.07	-0.97	1.33	2.27	3.05
Cash from operations	4.75	2.62	5.07	4.96	10.9	17.4	16.9	10.6	12	12
Acquisitions	0				0	-33.7	-32.4	-9.75	-1.7	0
Cash from investing	-0.1	-0.12	0.15	9.81	0.04	-29.4	-23.6	-7.08	0.04	0.3
Debt issued						3.2	12.4	1.58
Debt repaid						-0.09	-0.57	-3.35	-0.56	-0.09
Stock issued			0	0.16	0	0.03	0
Share buybacks	-0.38	-1.83	0	-8.37	-0.15	0			0	-0.38
Dividends paid				0	-1.36	-3.14	-3.31
Cash from financing	0.09	-2.28	-4.21	-11.9	-1.44	-0.35	8.49	-5.24	-11.2	-10.7
Net change in cash	4.73	0.22	1.02	2.9	9.48	-12.4	1.79	-1.71	0.88	1.68
Interest paid	0.01	0	0	0.56	0.05	0.11	0.27	1.35	0.96	0.28
Income taxes paid	0.52	0.02	0	1.82	2.82	0.89	3.05	2.82	1.17	0.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $20.04 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	28.4%	Operating income / revenue.
EBITDA margin	38.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	30.7%	Pre-tax income / revenue.
Net margin	27.1%	Net income / revenue.
Operating cash flow margin	31.5%	Cash from operations / revenue.
Effective tax rate	8.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	11.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.7%	Net income / average total assets.
Return on invested capital (ROIC)	11.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	59.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.7%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	10.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-11.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	17.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	43.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-26.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	4.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	29.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-19.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	12.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	72.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-20.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	3.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	73.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-20.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	2.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	0.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-10.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	58.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	5.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-6.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-5.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.74x	Current assets / current liabilities.
Quick ratio	2.50x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	26.3%	Total liabilities / total assets.
Interest coverage	65.5x	Operating income / interest expense.
Working capital	$35.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	21.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$48.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.32x	Revenue / average total assets.
Fixed asset turnover	7.61x	Revenue / average property, plant and equipment.
Receivables turnover	0.62x	Revenue / average receivables.
Days sales outstanding	591 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.59	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$2.18	Revenue / diluted weighted shares.
Operating cash flow per share	$0.69	Cash from operations / diluted weighted shares.
Book value per share	$4.99	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.52	Tangible book value / shares outstanding.
Cash per share	$0.12	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$278.6M	Share price x shares outstanding.
Enterprise value	$276.9M	Market cap + total debt - cash - short-term investments.
P/E	34.1x	Market cap / net income. Only when net income is positive.
P/S	9.24x	Market cap / revenue.
P/B	4.05x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.73x	Market cap / tangible book value, when positive.
P/OCF	29.4x	Market cap / cash from operations, when positive.
EV/Sales	9.18x	Enterprise value / revenue.
EV/EBIT	32.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	23.8x	Enterprise value / EBITDA, when both are positive.
Earnings yield	2.9%	Net income / market cap (the inverse of P/E).

What was HireQuest, Inc.'s revenue in fiscal 2025?

HireQuest, Inc. reported revenue of $30.6M for fiscal 2025, 11.4% lower than the year before.

Was HireQuest, Inc. profitable in fiscal 2025?

Yes. Net income was $6.3M, a net margin of 20.7%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HireQuest, Inc.